Clinical implication of 14-3-3 epsilon expression in gastric cancer
Authors:
- Mariana Ferreira LealMLMariana Ferreira Leal
- Danielle Queiroz CalcagnoDCDanielle Queiroz Calcagno
- Sâmia DemachkiSDSâmia Demachki
- Paulo Pimentel AssumpçãoPAPaulo Pimentel Assumpção
- Roger ChammasRCRoger Chammas
- Rommel Rodríguez BurbanoRBRommel Rodríguez Burbano
- Marília De Arruda Cardoso SmithMSMarília De Arruda Cardoso Smith
Open Access
- 1 January 2012
- journal article
- research article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (13) , 1531-7
Abstract
To evaluate for the first time the protein and mRNA expression of 14-3-3ε in gastric carcinogenesis. 14-3-3ε protein expression was determined by western blotting, and mRNA expression was examined by real-time quantitative RT-PCR in gastric tumors and their matched non-neoplastic gastric tissue samples. Authors observed a significant reduction of 14-3-3ε protein expression in gastric cancer (GC) samples compared to their matched non-neoplastic tissue. Reduced levels of 14-3-3ε were also associated with diffuse-type GC and early-onset of this pathology. Our data suggest that reduced 14-3-3ε may have a role in gastric carcinogenesis process. Our results reveal that the reduced 14-3-3ε expression in GC and investigation of 14-3-3ε interaction partners may help to elucidate the carcinogenesis process.Keywords
This publication has 47 references indexed in Scilit:
- MYC, TP53, and Chromosome 17 Copy‐Number Alterations in Multiple Gastric Cancer Cell Lines and in Their Parental Primary TumorsBioMed Research International, 2011
- Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants.Plant Molecular Biology, 2002
- 14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine PhosphorylationJournal of Biological Chemistry, 2002
- Gastric carcinoma in young adults.2002
- Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.2002
- How do 14‐3‐3 proteins work? – Gatekeeper phosphorylation and the molecular anvil hypothesisFEBS Letters, 2001
- 14‐3‐3 proteins: key regulators of cell division, signalling and apoptosisBioEssays, 2001
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- C-myc amplification and cluster analysis in human gastric carcinoma.2001
- 14-3-3 Proteins: Structure, Function, and RegulationAnnual Review of Pharmacology and Toxicology, 2000